Montelukast sodium in cystic fibrosis [2]

Thorax

Volumn 56, Issue 3, 2001, Pages 244-245

  Morice, A H ^a   Kastelik, J A ^a   Aziz, I ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOTRIENE D4; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST;

ADOLESCENT; ADULT; ASPERGILLUS FUMIGATUS; CLINICAL ARTICLE; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATION; LETTER; LUNG FUNCTION; MALE; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; SYMPTOMATOLOGY; TH2 CELL;

ACETATES; ADOLESCENT; ADULT; ASTHMA; CYSTIC FIBROSIS; EXERCISE TOLERANCE; FEMALE; HUMANS; LEUKOTRIENE ANTAGONISTS; MALE; QUINOLINES; TREATMENT OUTCOME;

EID: 0035089206     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.56.3.244     Document Type: Letter

References (7)

1. Identification of leukotrienes-D and B in sputum from cystic fibrosis patients
2. Leukotrienes in the sputum and urine of cystic fibrosis children
3. Detection of sputum eicosanoids in cystic fibrosis and in normal saliva by bioassay and radioimmunoassay
4. Sputum cysteinyl-leukotriene levels correlate with the severity of pulmonary-disease in children with cystic fibrosis
5. Prevalence of allergic bronchopulmonary aspergillosis and atopy in adult patients with cystic fibrosis
6. Allergic bronchopulmonary mycosis complicating cystic fibrosis
7. H2-like bronchoalveolar T-lymphocyte population in atopic asthma